GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DA) » Definitions » Operating Margin %

Melodiol Global Health (ASX:ME1DA) Operating Margin % : -29.41% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Melodiol Global Health's Operating Income for the six months ended in Dec. 2023 was A$-3.51 Mil. Melodiol Global Health's Revenue for the six months ended in Dec. 2023 was A$11.93 Mil. Therefore, Melodiol Global Health's Operating Margin % for the quarter that ended in Dec. 2023 was -29.41%.

Good Sign:

Melodiol Global Health Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Melodiol Global Health's Operating Margin % or its related term are showing as below:

ASX:ME1DA' s Operating Margin % Range Over the Past 10 Years
Min: -52287.5   Med: -521.46   Max: -88.16
Current: -88.16


ASX:ME1DA's Operating Margin % is ranked worse than
86.76% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 6.075 vs ASX:ME1DA: -88.16

Melodiol Global Health's 5-Year Average Operating Margin % Growth Rate was 40.20% per year.

Melodiol Global Health's Operating Income for the six months ended in Dec. 2023 was A$-3.51 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-16.68 Mil.

Warning Sign:

Melodiol Global Health Ltd has never been profitable in the past 3 years. It lost money every year.


Melodiol Global Health Operating Margin % Historical Data

The historical data trend for Melodiol Global Health's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Operating Margin % Chart

Melodiol Global Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial -280.61 -586.93 -455.98 -220.88 -88.16

Melodiol Global Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -346.78 -160.90 -280.10 -188.31 -29.41

Competitive Comparison of Melodiol Global Health's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Operating Margin % falls into.



Melodiol Global Health Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Melodiol Global Health's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-16.68 / 18.921
=-88.16 %

Melodiol Global Health's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-3.508 / 11.926
=-29.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Melodiol Global Health  (ASX:ME1DA) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Melodiol Global Health Operating Margin % Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health (ASX:ME1DA) Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DA) Headlines

No Headlines